CERO THERAPEUTICS HOLDINGS, INC.
SOUTH SAN FRANCISCO, CA · Founded 2021 · CIK 0001870404 · Biotech · Public
Engineered T cell therapies with multi-modal tumor clearance mechanisms
cero.bio →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $16M
- 3 Form D · May 2025
- 17 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 2 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $10,193,654 | |
| Private capital raised | Form D · SEC | $1,250,000 | |
| Private capital raised | Form D · SEC | $5,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2315 | Bond Biosciences, Inc. | — | $18M |
| 2316 | Moleculin Biotech, Inc. | — | $6.0M |
| 2317 | ProtoKinetix, Inc. | — | $3.8M |
| 2318 | CERO THERAPEUTICS HOLDINGS, INC. | — | $16M |
| 2319 | INMUNE BIO, INC. | — | $8.0M |
| 2320 | ARUKA BIO, INC. | — | $3.6M |
| 2321 | Genomics PLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Brian AtwoodDirector · Executive Officer
- Michael ByrnesDirector
- Chris EhrlichDirector · Executive Officer
- Andrew KucharchukExecutive Officer
- Kathleen LaPorteDirector
- Shami PatelDirector
- Kristen PierceExecutive Officer
- Robyn RapaportDirector
- Lindsey RolfeDirector
Patents
- Chimeric Tim Receptors And Uses Thereofapplication
- Chimeric Tim Receptors And Uses Thereofgranted
- Cellular Immunotherapy Compositions And Uses Thereofapplication
- Chimeric TIM4 Receptors And Uses Thereofapplication
- Compositions And Methods For Treating Cancer With Chimeric Tim Receptors In Combination With Inhibitors Of Poly (adp-ribose) Polymeraseapplication
- Chimeric TIM4 Receptors And Uses Thereofgranted
- Chimeric TIM4 Receptors And Uses Thereofapplication
- ANTI-CD72 Chimeric Receptors And Uses Thereofapplication
- Chimeric Tim Receptors And Uses Thereofapplication
- Chimeric Engulfment Receptor Molecules And Methods Of Useapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.